
Interim Considerations: Preparing for the Potential Management of Anaphylaxis after COVID-19 Vaccination
Authors: CDC Summary of recent changes (last updated March 3, 2021) Considerations broadened to include use of Janssen (Johnson & Johnson) COVID-19 vaccine. Key Points Under the Emergency Use Authorizationsexternal icon for…[...]
Read More